Le Lézard
Classified in: Health
Subjects: PDT, WOM, MAT

New, At-Home Device Helps Women Detect Lesions in Breast Tissue


MIAMI, Jan. 30, 2018 /PRNewswire/ -- Recently making headlines with its breakthrough technology and spreading consciousness, Pink Luminous Breast is a breast familiarity and assistance tool designed to use anywhere, anytime. Pink Luminous Breast allows women to observe veins and visually check for lesions in breast tissue. It is a one of a kind product in providing awareness, as a preliminary screening tool to assist women in their in-home regular breast care routine. The company's goal is to promote early detection of breast cancer in as many women as possible through at home self-breast-exams and routine mammograms.

Sooner or later, it seems, cancer has an impact on us all. That's why World Cancer Day on February 4th is an important day to raise awareness about prevention, detection, and treatment. The Pink Luminous Breast hand-held device is designed to observe the breast and carefully look for shadows or dark areas which could be a sign of potential lesions. Based out of the USA, Pink Luminous Breast was developed with the purpose of increasing breast awareness to the user in between regular mammograms and screenings.

At a convention for medical devices, Marilyn Dans, the president and founder of Pink Luminous Breast, made contact with the inventor of the laser diode and instantly knew she had to pursue the development of the device. The inventor and president combined their skills and expertise to design and produce Pink Luminous Breast.

Dans urges women to lead an "awareness lifestyle" and to take ownership of their health and notes the best protection is early detection. Helping people on their path to better health, Dans' company SilkProUSA, created Pink Luminous Breast as an innovative, safe, and effective way for women to better understand their breast health in the comfort of their homes.

The device hones in on Angiogenesis, which refers to the formation of new blood vessels in the body. It is a normal bodily process for healing but also plays a role in the growth of cancer. Cancers require the formation of new blood vessels to grow and metastasize. Cancers do this by secreting substances that stimulate angiogenesis, leading to the growth of cancer.

Pink Luminous Breast works by illuminating tissue through RED LED-light technology. When a woman uses Pink Luminous Breast, tiny fractions of light pass through the breast to reveal potential problem areas. The FDA-registered class 1 medical device works with that fine spectrum light, which in turn illuminates veins ?including dark clusters that may indicate potential abnormalities and lumps that increase blood supply to dense areas. The bright light intensifies only upon skin contact and the device is completely harmless with zero side effects.

"I knew immediately the device was something I had a spiritual obligation to pursue primarily because of the emotional distress breast cancer caused my family and I, as well as the millions of families affected by this devastating disease which consumes so much more than just its host cells," Dans said.

Dans notes that death rates have dropped a staggering 38% since the 1980's in relation to breast cancer and it's thought to be due to advances in technology and increased breast awareness in the recent decades. "This is why Pink Luminous Breast is passionate about increasing breast consciousness-we know that early detection is key," says Dans.

Dans believes Pink Luminous Breast being should be available to everyone and because of this her company has created the "Pink Luminous Advocacy Project" a non-profit organization that enables Dans to provide the device to third world countries, where more advanced technologies are not an economic option.

Pink Luminous Breast retails at $149 and can be found in some doctor's offices, www.sharperimage.com, www.shop.com, www.amazon.com and www.pinkluminousbreast.com.

Media Contact: 
TARA, Ink.   
305.864.3434  
Nick D'Annunzio; [email protected]  

SOURCE Pink Luminous Breast


These press releases may also interest you

at 11:34
At the Annual General Meeting of Vitrolife AB today, the following, amongst other things, was decided: Resolution in accordance with the Board's proposed dividend of SEK 1.00 per share for the financial year 2023. 29 April, 2024 was adopted as the...

at 11:25
TimelyCare, higher education's most trusted virtual health and well-being provider, has earned recognition as one of the World's Best Digital Health Companies by Newsweek, and has been awarded five Top Workplaces Awards for culture excellence....

at 11:16
Avanos Medical, Inc. will webcast its conference call discussing financial results and business highlights for the first quarter 2024 on Thursday, May 2 at 9 a.m., ET. The company will issue a news release detailing its results before the market...

at 11:15
Beijing Avistone Biotechnology Co., Ltd. (also referred to as Avistone Biotechnology or Avistone), an innovative biotechnology company focused on precision oncology therapeutics, announced the approval to expand the use of vebreltinib (also referred...

at 11:10
Through its 2030 Strategic Plan, NJII plans to double the size of the organization and to exceed $70M revenue as it rolls out various new initiatives focused on accelerating technology translation, spurring innovation and upskilling workers. As...

at 11:09
ScreenPoint Medical, today announced a significant transition in its leadership as Mark Koeniguer, the current CEO, steps down from his position. Mark served as CEO since 2022 and was instrumental in ScreenPoint's commercial growth and success over...



News published on and distributed by: